International Orthopaedics

, Volume 42, Issue 12, pp 2941–2948 | Cite as

Risk factors for metastasis at presentation with conventional chondrosarcoma: a population-based study

  • Kehan Song
  • Xiao Shi
  • Xin Liang
  • Hongli Wang
  • Fei Zou
  • Feizhou Lu
  • Xiaosheng Ma
  • Jianyuan JiangEmail author
Original Paper



The aim of the study was to investigate risk factors for metastasis at diagnosis.


We collected patients diagnosed with conventional chondrosarcoma between 1983 and 2014 from the Surveillance, Epidemiology, and End Results (SEER) database. Each patient was classified as having metastatic or localized disease. Univariate and multivariate logistic regression analyses were applied to determine which characteristics were risk factors for metastasis at diagnosis.


Two thousand three hundred forty-nine patients were collected and 180 patients had metastasis at presentation. Data on age, gender, primary site, grade, and tumour size were enrolled into the multivariate logistic analysis. Greater age (60 years or older: OR = 1.872, 95% CI, 1.206 to 2.904), axial or craniofacial location (spine: OR = 1.775, 95% CI, 1.188 to 2.651; thoracic cage: OR = 2.034, 95% CI, 1.321 to 3.134; craniofacial bones: OR = 5.507, 95% CI, 3.001 to 10.107), higher grade (grade II: OR = 1.849, 95%CI, 1.181 to 2.895; grade III: OR = 4.016, 95%CI, 2.513 to 6.418), and larger tumour size (size over 10 cm: OR = 7.135, 95%CI, 2.130 to 23.893) were associated with an increased risk of metastasis at presentation.


Conventional chondrosarcoma patients with greater age, axial or craniofacial tumour location, higher grade, and larger tumor size were more likely to have metastasis at diagnosis.


Bone cancer Conventional chondrosarcoma Risk factor Metastasis 


Compliance with ethical standards

Conflict of interest

The authors declare that they have no conflict of interest.

Ethical approval

Because we obtain data from the SEER database with open access, we did not need to acquire patient consent or ethical review committee statement, but we were required to sign a Data-Use Agreement for the SEER 1973–2014 Research Data File to gain access to the SEER database.


  1. 1.
    Biermann JS, Chow W, Reed DR, Lucas D, Adkins DR, Agulnik M, Benjamin RS, Brigman B, Budd GT, Curry WT, Didwania A, Fabbri N, Hornicek FJ, Kuechle JB, Lindskog D, Mayerson J, McGarry SV, Million L, Morris CD, Movva S, O'Donnell RJ, Randall RL, Rose P, Santana VM, Satcher RL, Schwartz H, Siegel HJ, Thornton K, Villalobos V, Bergman MA, Scavone JL (2017) NCCN guidelines insights: bone cancer, version 2.2017. J Natl Compr Cancer Netw 15(2):155–167CrossRefGoogle Scholar
  2. 2.
    Fletcher CDM, Bridge JA, Hogendoorn P, Mertens F (2013) WHO classification of tumours of soft tissue and bone, vol 5, 4th edn. IARC Press, LyonGoogle Scholar
  3. 3.
    Mankin HJ, Cantley KP, Schiller AL, Lippiello L (1980) The biology of human chondrosarcoma. II. Variation in chemical composition among types and subtypes of benign and malignant cartilage tumors. J Bone Joint Surg Am 62(2):176–188CrossRefPubMedGoogle Scholar
  4. 4.
    Gelderblom H, Hogendoorn PC, Dijkstra SD, van Rijswijk CS, Krol AD, Taminiau AH, Bovee JV (2008) The clinical approach towards chondrosarcoma. Oncologist 13(3):320–329. CrossRefPubMedGoogle Scholar
  5. 5.
    Giuffrida AY, Burgueno JE, Koniaris LG, Gutierrez JC, Duncan R, Scully SP (2009) Chondrosarcoma in the United States (1973 to 2003): an analysis of 2890 cases from the SEER database. J Bone Joint Surg Am 91(5):1063–1072. CrossRefPubMedGoogle Scholar
  6. 6.
    van Maldegem AM, Gelderblom H, Palmerini E, Dijkstra SD, Gambarotti M, Ruggieri P, Nout RA, van de Sande MA, Ferrari C, Ferrari S, Bovee JV, Picci P (2014) Outcome of advanced, unresectable conventional central chondrosarcoma. Cancer 120(20):3159–3164. CrossRefPubMedGoogle Scholar
  7. 7.
    Nota SP, Braun Y, Schwab JH, van Dijk CN, Bramer JA (2015) The identification of prognostic factors and survival statistics of conventional central chondrosarcoma. Sarcoma 2015:623746. CrossRefPubMedPubMedCentralGoogle Scholar
  8. 8.
    Jawad MU, Haleem AA, Scully SP (2011) Malignant sarcoma of the pelvic bones: treatment outcomes and prognostic factors vary by histopathology. Cancer 117(7):1529–1541. CrossRefPubMedGoogle Scholar
  9. 9.
    Bruns J, Elbracht M, Niggemeyer O (2001) Chondrosarcoma of bone: an oncological and functional follow-up study. Ann Oncol 12(6):859–864CrossRefPubMedGoogle Scholar
  10. 10.
    Angelini A, Guerra G, Mavrogenis AF, Pala E, Picci P, Ruggieri P (2012) Clinical outcome of central conventional chondrosarcoma. J Surg Oncol 106(8):929–937. CrossRefPubMedGoogle Scholar
  11. 11.
    Andreou D, Ruppin S, Fehlberg S, Pink D, Werner M, Tunn PU (2011) Survival and prognostic factors in chondrosarcoma: results in 115 patients with long-term follow-up. Acta Orthop 82(6):749–755. CrossRefPubMedPubMedCentralGoogle Scholar
  12. 12.
    Thampi S, Matthay KK, Goldsby R, DuBois SG (2013) Adverse impact of regional lymph node involvement in osteosarcoma. Eur J Cancer 49(16):3471–3476. CrossRefPubMedGoogle Scholar
  13. 13.
    Schneiderman BA, Kliethermes SA, Nystrom LM (2017) Survival in mesenchymal chondrosarcoma varies based on age and tumor location: a survival analysis of the SEER database. Clin Orthop Relat Res 475(3):799–805. CrossRefPubMedGoogle Scholar
  14. 14.
    Mukherjee D, Chaichana KL, Parker SL, Gokaslan ZL, McGirt MJ (2013) Association of surgical resection and survival in patients with malignant primary osseous spinal neoplasms from the Surveillance, Epidemiology, and End Results (SEER) database. Eur Spine J 22(6):1375–1382. CrossRefPubMedGoogle Scholar
  15. 15.
    Miller BJ, Cram P, Lynch CF, Buckwalter JA (2013) Risk factors for metastatic disease at presentation with osteosarcoma: an analysis of the SEER database. J Bone Joint Surg Am 95(13):e89. CrossRefPubMedPubMedCentralGoogle Scholar
  16. 16.
    Duchman KR, Lynch CF, Buckwalter JA, Miller BJ (2014) Estimated cause-specific survival continues to improve over time in patients with chondrosarcoma. Clin Orthop Relat Res 472(8):2516–2525. CrossRefPubMedPubMedCentralGoogle Scholar
  17. 17.
    Applebaum MA, Goldsby R, Neuhaus J, DuBois SG (2012) Clinical features and outcomes in patients with Ewing sarcoma and regional lymph node involvement. Pediatr Blood Cancer 59(4):617–620. CrossRefPubMedGoogle Scholar
  18. 18.
    Söderstrom M, Ekfors TO, Böhling TO, Teppo LHI, Vuorio EI, Aro HT (2009) No improvement in the overall survival of 194 patients with chondrosarcoma in Finland in 1971–1990. Acta Orthop Scand 74(3):344–350. CrossRefGoogle Scholar
  19. 19.
    Lee FY, Mankin HJ, Fondren G, Gebhardt MC, Springfield DS, Rosenberg AE, Jennings LC (1999) Chondrosarcoma of bone: an assessment of outcome. J Bone Joint Surg Am 81(3):326–338CrossRefPubMedGoogle Scholar
  20. 20.
    Sanerkin NG (1980) The diagnosis and grading of chondrosarcoma of bone: a combined cytologic and histologic approach. Cancer 45(3):582–594CrossRefPubMedGoogle Scholar
  21. 21.
    Ozaki T, Lindner N, Hillmann A, Rodl R, Blasius S, Winkelmann W (1996) Influence of intralesional surgery on treatment outcome of chondrosarcoma. Cancer 77(7):1292–1297CrossRefPubMedGoogle Scholar
  22. 22.
    Bjornsson J, McLeod RA, Unni KK, Ilstrup DM, Pritchard DJ (1998) Primary chondrosarcoma of long bones and limb girdles. Cancer 83(10):2105–2119CrossRefPubMedGoogle Scholar
  23. 23.
    Fahey M, Spanier SS, Vander Griend RA (1992) Osteosarcoma of the pelvis. A clinical and histopathological study of twenty-five patients. J Bone Joint Surg Am 74(3):321–330CrossRefPubMedGoogle Scholar
  24. 24.
    Kawai A, Huvos AG, Meyers PA, Healey JH (1998) Osteosarcoma of the pelvis. Oncologic results of 40 patients. Clin Orthop Relat Res 348:196–207CrossRefGoogle Scholar
  25. 25.
    Bramer JA, Abudu AA, Grimer RJ, Carter SR, Tillman RM (2007) Do pathological fractures influence survival and local recurrence rate in bony sarcomas? Eur J Cancer 43(13):1944–1951. CrossRefPubMedGoogle Scholar

Copyright information

© SICOT aisbl 2018

Authors and Affiliations

  • Kehan Song
    • 1
  • Xiao Shi
    • 2
  • Xin Liang
    • 3
  • Hongli Wang
    • 1
  • Fei Zou
    • 1
  • Feizhou Lu
    • 1
  • Xiaosheng Ma
    • 1
  • Jianyuan Jiang
    • 1
    Email author
  1. 1.Department of Orthopaedics, Huashan HospitalFudan UniversityShanghaiChina
  2. 2.Department of Oncology, Shanghai Medical CollegeFudan UniversityShanghaiChina
  3. 3.Department of Ophthalmology, Shanghai Medical CollegeFudan UniversityShanghaiChina

Personalised recommendations